Literature DB >> 27018907

Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.

Aaron T Garrison1, Yasmeen Abouelhassan1, Verrill M Norwood1, Dimitris Kallifidas1, Fang Bai1, Minh Thu Nguyen1, Melanie Rolfe1, Gena M Burch1, Shouguang Jin1, Hendrik Luesch1, Robert W Huigens1.   

Abstract

Persistent bacteria, including persister cells within surface-attached biofilms and slow-growing pathogens lead to chronic infections that are tolerant to antibiotics. Here, we describe the structure-activity relationships of a series of halogenated phenazines (HP) inspired by 2-bromo-1-hydroxyphenazine 1. Using multiple synthetic pathways, we probed diverse substitutions of the HP scaffold in the 2-, 4-, 7-, and 8-positions, providing critical information regarding their antibacterial and bacterial eradication profiles. Halogenated phenazine 14 proved to be the most potent biofilm-eradicating agent (≥99.9% persister cell killing) against MRSA (MBEC < 10 μM), MRSE (MBEC = 2.35 μM), and VRE (MBEC = 0.20 μM) biofilms while 11 and 12 demonstrated excellent antibacterial activity against M. tuberculosis (MIC = 3.13 μM). Unlike antimicrobial peptide mimics that eradicate biofilms through the general lysing of membranes, HPs do not lyse red blood cells. HPs are promising agents that effectively target persistent bacteria while demonstrating negligible toxicity against mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27018907     DOI: 10.1021/acs.jmedchem.5b02004

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  24 in total

1.  Physiological Evidence for Isopotential Tunneling in the Electron Transport Chain of Methane-Producing Archaea.

Authors:  Nikolas Duszenko; Nicole R Buan
Journal:  Appl Environ Microbiol       Date:  2017-08-31       Impact factor: 4.792

2.  Natural products as inspiration for the development of bacterial antibiofilm agents.

Authors:  Roberta J Melander; Akash K Basak; Christian Melander
Journal:  Nat Prod Rep       Date:  2020-07-01       Impact factor: 13.423

3.  Transcript Profiling of MRSA Biofilms Treated with a Halogenated Phenazine Eradicating Agent: A Platform for Defining Cellular Targets and Pathways Critical to Biofilm Survival.

Authors:  Yasmeen Abouelhassan; Yanping Zhang; Shouguang Jin; Robert W Huigens
Journal:  Angew Chem Int Ed Engl       Date:  2018-10-25       Impact factor: 15.336

Review 4.  Instructive Advances in Chemical Microbiology Inspired by Nature's Diverse Inventory of Molecules.

Authors:  Ke Liu; Robert W Huigens
Journal:  ACS Infect Dis       Date:  2020-01-06       Impact factor: 5.084

Review 5.  Natural Products as Platforms To Overcome Antibiotic Resistance.

Authors:  Sean E Rossiter; Madison H Fletcher; William M Wuest
Journal:  Chem Rev       Date:  2017-09-27       Impact factor: 60.622

Review 6.  Phenazine Antibiotic-Inspired Discovery of Bacterial Biofilm-Eradicating Agents.

Authors:  Robert W Huigens; Yasmeen Abouelhassan; Hongfen Yang
Journal:  Chembiochem       Date:  2019-10-02       Impact factor: 3.164

Review 7.  Recent Progress in Natural-Product-Inspired Programs Aimed To Address Antibiotic Resistance and Tolerance.

Authors:  Yasmeen Abouelhassan; Aaron T Garrison; Hongfen Yang; Alejandra Chávez-Riveros; Gena M Burch; Robert W Huigens
Journal:  J Med Chem       Date:  2019-04-18       Impact factor: 7.446

8.  Progress towards a stable cephalosporin-halogenated phenazine conjugate for antibacterial prodrug applications.

Authors:  Tao Xiao; Ke Liu; Robert W Huigens
Journal:  Bioorg Med Chem Lett       Date:  2020-08-27       Impact factor: 2.823

9.  Eradicating uropathogenic Escherichia coli biofilms with a ciprofloxacin-dinitroxide conjugate.

Authors:  Anthony D Verderosa; Jessica Harris; Rabeb Dhouib; Makrina Totsika; Kathryn E Fairfull-Smith
Journal:  Medchemcomm       Date:  2019-02-25       Impact factor: 3.597

10.  Design, synthesis and biological evaluation of a halogenated phenazine-erythromycin conjugate prodrug for antibacterial applications.

Authors:  Hongfen Yang; Ke Liu; Shouguang Jin; Robert W Huigens Iii
Journal:  Org Biomol Chem       Date:  2021-02-25       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.